Advaxis to Present an Overview of its Lm Platform and New Information on its Neoantigen-Directed Therapy Programs at the Immuno-Oncology 360° Conference
Stock Information for Advaxis Inc.
Loading
Please wait while we load your information from QuoteMedia.